Covidien plc (COV) Announces New Bipolar Resection Software Application for ForceTriad™ Energy Platform  
7/12/2012 10:39:07 AM

BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the North American introduction of a new bipolar resection in saline software application for its ForceTriad™ energy platform. With this new application, surgeons may now perform transurethral resections of the prostate using TissueFect™ sensing technology available with the ForceTriad energy platform.